"muscle invasive bladder cancer" trang 1 - tải miễn phí từ tailieuXANH
Management of non-muscle-invasive bladder cancer: Quality of clinical practice guidelines and variations in recommendations

Management of non-muscle-invasive bladder cancer: Quality of clinical practice guidelines and variations in recommendations
12    64    0
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscleinvasive bladder cancer

Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscleinvasive bladder cancer
9    51    0
Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: Mechanism of action of P-MAPA biological response modifier

Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: Mechanism of action of P-MAPA biological response modifier
18    75    0
Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: A retrospective non-randomized comparative study

Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: A retrospective non-randomized comparative study
11    42    1
Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: A multicenter retrospective study

Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: A multicenter retrospective study
8    36    1
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes
9    67    0
Protocol of the Italian Radical Cystectomy Registry (RIC): A non-randomized, 24- month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer

Protocol of the Italian Radical Cystectomy Registry (RIC): A non-randomized, 24- month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer
9    43    1
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
9    60    0
Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer

Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
9    52    0
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: A phase II trial

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: A phase II trial
6    78    0
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response
4    78    0
Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies
15    77    0
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
15    13    1
Urinary UBC rapid and NMP22 test for bladder cancer surveillance in comparison to urinary cytology: Results from a prospective single-center study

Urinary UBC rapid and NMP22 test for bladder cancer surveillance in comparison to urinary cytology: Results from a prospective single-center study
9    64    0
Down-regulation of A-FABP predicts nonmuscle invasive bladder cancer progression: Investigation with a long term clinical follow-up

Down-regulation of A-FABP predicts nonmuscle invasive bladder cancer progression: Investigation with a long term clinical follow-up
13    90    0
Utility of SAM68 in the progression and prognosis for bladder cancer

Utility of SAM68 in the progression and prognosis for bladder cancer
8    58    0
High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
10    59    0
Laminin-integrin a6b4 interaction activates notch signalling to facilitate bladder cancer development

Laminin-integrin a6b4 interaction activates notch signalling to facilitate bladder cancer development
11    21    1
Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer
6    46    0
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: A Markov model

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: A Markov model
8    78    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.